Hildo Lantermans

Standard PhD Candidate, Doctoral School
Other Academic Staff, CCA - Cancer biology and immunology (AMC)
Standard PhD Candidate, CCA - Cancer biology and immunology (AMC)
Other Academic Staff, AII - Cancer immunology (AMC)
Standard PhD Candidate, AII - Cancer immunology (AMC)
Research Associate, Paediatric Nephrology (AMC)

Research activity per year

2 Article

2 results

Filter

2023

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain
Minderman, M., Lantermans, H., van der Zwaan, C., Hoogendijk, A. J., van den Biggelaar, M., Kersten, M. J., Spaargaren, M. & Pals, S. T., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 125.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

1 Citation (Scopus)
2021

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
Lantermans, H. C., Minderman, M., Kuil, A., Kersten, M-J., Pals, S. T. & Spaargaren, M., Mar 2021, In: Leukemia. 35, 3, p. 881-886 6 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

11 Citations (Scopus)